-
Signature
-
/s/ Michelle Webb, Attorney-in-Fact
-
Issuer symbol
-
ACVA
-
Transactions as of
-
17 Sep 2024
-
Transactions value $
-
-$7,118,364
-
Form type
-
4
-
Filing time
-
19 Sep 2024, 17:40:03 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACVA |
Class A Common Stock |
Conversion of derivative security |
|
+111,363 |
+12% |
|
1,039,529 |
17 Sep 2024 |
Direct |
F1 |
| transaction |
ACVA |
Class A Common Stock |
Sale |
-$2,257,328 |
-111,363 |
-10.71% |
$20.27 |
928,166 |
17 Sep 2024 |
Direct |
F2, F3 |
| transaction |
ACVA |
Class A Common Stock |
Conversion of derivative security |
|
+238,637 |
+25.71% |
|
1,166,803 |
18 Sep 2024 |
Direct |
F1 |
| transaction |
ACVA |
Class A Common Stock |
Sale |
-$4,861,035 |
-238,637 |
-20.45% |
$20.37 |
928,166 |
18 Sep 2024 |
Direct |
F2, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ACVA |
Class B Common Stock |
Conversion of derivative security |
$0 |
-111,363 |
-5.34% |
$0 |
1,975,493 |
17 Sep 2024 |
Class A Common Stock |
111,363 |
|
Direct |
F1, F5 |
| transaction |
ACVA |
Class B Common Stock |
Conversion of derivative security |
$0 |
-238,637 |
-12.08% |
$0 |
1,736,856 |
18 Sep 2024 |
Class A Common Stock |
238,637 |
|
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: